Stockreport

Taysha Gene Therapies: Unjustified Sell-Off - Enough Cash Runway And Promising Rett Syndrome Data [Seeking Alpha]

Taysha Gene Therapies, Inc.  (TSHA) 
PDF Play 13min Summary Taysha Gene Therapies' TSHA-102 shows promising results for Rett syndrome, leveraging miRARE technology to modulate MECP2 expression, improving [Read more]